mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.7 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |